Optimization of treatment of endometrial hyperplastic processes in the late reproductive period by hysteroscopic сold loop technique

С. М. Корнієнко

Abstract


The aim of the study was to evaluate the effectiveness of various methods of hyperplastic endometrium removing in late reproductive age women.

Materials and methods. In the prospective cohort study 321 women 35–44 year aged with hyperplastic endometrium processes were selected by the continuous sample method. Depending on the method of treatment of this pathology, the patients were divided into two groups: the Ith group included 143 women whom, after hysteroscopic confirmation of the diagnosis, the hyperplastic endometrium was removed using the “cold loop” technique with the further complex scheme of treatment which included therapy by synthetic gestagens, sedative therapy and use of drugs of melatonin (in the presence of disorders of a dream and hypomelatoninemia). The II group included 178 women, whom after hysteroscopic confirmation of the diagnosis, curettage of a cavity of the uterus was performed, the subsequent hormonal therapy by synthetic gestagena was used according to the Clinical protocol “Endometrial Hyperplasia” (the order of the MOH of Ukraine No. 676 from 31.12.2004). The women of both groups did not differ significantly by age, menstrual cycle peculiarities, gynecological, reproductive, somatic anamnesis and complaints.

Results and conclusions. Analisis of the long-term results of endometrial pathology treatment showed that among I-th group women recurrence of hyperplastic endometrium processes was observed several times less often (p <0.05). The author came to the conclusion that the removal of hyperplastic endometrium by the “cold loop” technique allows to significantly reduce the hyperplastic endometrium processes recurrence and newly detected intrauterine pathology level in comparison with endometrial curretage.


Keywords


endometrial hyperplastic processes; late reproductive age; endometrial curettage; cold loop; hysteroscopy

References


Chepik, O.F. “Morphogenesis of endometrial hyperplastic processes.” Practical oncology 5.1 (2004): 9–15.

Kuznetsova, I.V. “Possibilities of therapy of endometrial hyperplastic processes.” Difficult patient 8.1–2 (2010): 18–22.

Chernuha, G.E. “Adenomatous and glandular hyperplasia of the endometrium in the reproductive age (pathogenesis, clinic, treatment). ” Thesis abstract for MD degree. Moscow (1999).

Tatarchuk, T.F., Kalugina, L.V., Tutchenko T.N. “Hyperplastic processes of the endometrium: what’s new?” Reproductive endocrinology 25.5 (2015): 7–13.

Order of the MOH of Ukraine No. 676 from 31.12.2004. Clinical protocol “Endometrial hyperplasia.»

Zaporozhan, V.N., Tatarchuk, T.F., Dubinina, V.G., Kosei, N.V. “Modern diagnostics and treatment of endometrial hyperplastic processes.” Reproductive endocrinology 3.1 (2012): 5–12.

Korniyenko, S.M. “Hysteroscopy in the diagnosis and treatment of intrauterine pathology in women of late reproductive and premenopausal age.” Pediatrics, Obstetrics and Gynecology 73.4 (2011): 219–22.

Patent for utility model № 82305. The method of surgical treatment of recurrent endometrial hyperplastic processes. Registered 25.07.2013. By Korniyenko S.M.

Ørbo, A., Arnes, M., Hancke, C., et al. “Treatment results of endometrial hyperplasia after prospective D‐score classification: a follow‐up study comparing effect of LNG‐IUD and oral progestins versus observation only.” Gynecol Oncol 111 (2008): 68–73.

Ørbo, A., Arnes, M., Vereide, A.B., Straume, B. “Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens.” BJOG 123.9 (2016): 1512–9.

Dubossarskaya, Z.M., Dubossarskaya, Y.A. “Endometrial hyperplasia (clinical lecture).” Women doctor 5 (2009): 22–7.

Veropotvelyan, P.N., Guzhevskaya, I.V., Veropotvelyan, N.P., Zhabitskaya, L.A. “Hyperplasia of the endometrium – a modern look at the problem.” Medical aspects of women’s health 10.74 (2013): 33–40.

Dankovich, N.A., Vorobei-Vikhovskaya, V.N. “Causes and forms of infertility. Modern diagnostic and treatment options.” Women’s health 3 (2013): 192–7.


GOST Style Citations


1. Чепик, О.Ф. Морфогенез гиперпластических процессов эндометрия / О.Ф.Чепик // Практическая онкология. – 2004. – №5 (1). – С. 9–15.

2. Кузнецова, И.В. Возможности терапии гиперпластических процессов эндометрия/ И.В. Кузнецова // Трудный пациент. – 2010. – №1–2, Т. 8. – С. 18–22.

3. Чернуха, Г.Е. Аденоматозная и железистая гиперплазия эндометрия в репродуктивном возрасте (патогенез, клиника, лечение) / Г.Е. Чернуха // Автореф. дисс. … д. м. н. – М.: 1999.

4. Татарчук, Т.Ф. Гиперпластические процессы эндометрия: что нового? / Т.Ф. Татарчук, Л.В. Калугина, Т.Н. Тутченко // Репродуктивна ендокринологія. – 2015. – №5 (25). – С. 7–13.

5. Наказ МОЗ України № 676 від 31.12.2004 р. Клінічний протокол «Гіперплазія ендометрія».

6. Запорожан, В.Н. Современная диагностика и лечение гиперпластических процессов эндометрия / В.Н. Запорожан, Т.Ф. Татарчук, В.Г. Дубинина, Н.В. Косей // Репродуктивна ендокринологія. – 2012. – №1(3). – С. 5–12.

7. Корнієнко, С.М. Гістероскопія в діагностиці та лікуванні внутрішньоматкової патології в жінок пізнього репродуктивного та пременопаузального віку / С.М. Корнієнко // Педіатрія, акушерство та гінекологія. – 2011. – Т. 73, № 4. – С. 219–222.

8. Патент на корисну модель № 82305. Спосіб хірургічного лікування рецидивуючих гіперпластичних процесів ендометрія. Зареєстровано 25.07.2013. Автор Корнієнко С.М.

9. Ørbo, A., Arnes, M., Hancke, C., et al. “Treatment results of endometrial hyperplasia after prospective D‐score classification: a follow‐up study comparing effect of LNG‐IUD and oral progestins versus observation only.” Gynecol Oncol 111 (2008): 68–73.

10. Ørbo, A., Arnes, M., Vereide, A.B., Straume, B. “Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens.” BJOG 123.9 (2016): 1512–9.

11. Дубоссарская, З.М. Гиперплазия эндометрия (клиническая лекция) / З.М. Дубоссарская, Ю.А. Дубоссарская // Жіночий лікар. – 2009. – №5. – С. 22–27.

12. Веропотвелян, П.Н. Гиперплазия эндометрия – современный взгляд на проблему / П.Н. Веропотвелян, И.В. Гужевская, Н.П. Веропотвелян, Л.А. Жабицкая // Медицинские аспекты здоровья женщины. – 2013. – №10 (74). – С. 33–40.

13. Данкович, Н.А. Причины и формы бесплодия. Современные возможности диагностики и лечения / Н.А. Данкович, В.Н. Воробей- Виховская // Здоровье женщины. – 2013. – №3. – С. 192–197.





DOI: https://doi.org/10.18370/2309-4117.2017.35.44-49

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)